| 心房颤动合并冠状动脉支架置入术患者的联合抗栓优化策略 |
| |
| 引用本文： | 陈忠秀,李晨,饶莉. 心房颤动合并冠状动脉支架置入术患者的联合抗栓优化策略[J]. 心血管病学进展, 2014, 0(2): 171-174 |
| |
| 作者姓名： | 陈忠秀 李晨 饶莉 |
| |
| 作者单位： | 四川大学华西医院心内科,四川成都610041 |
| |
| 摘 要： | 心房颤动患者合并冠状动脉支架置入术后应接受口服抗凝药和双联抗血小板药的三联抗栓治疗。然而，华法林联合阿司匹林和氯吡格雷的三联抗栓治疗出血风险高，哪种联合方式更加安全有效便成为抗栓治疗优化策略的关注焦点。现就心房颤动合并冠状动脉支架置入术患者的各种联合抗栓治疗方案的有效性及安全性综述如下。
|
| 关 键 词： | 心房颤动 冠状动脉支架置入 华法林 氯吡格雷 |
Optimizing Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Coronary Stenting |
| |
| Affiliation: | CHEN Zhongxiu, LIChen, RAO Li (Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China) |
| |
| Abstract: | Combining antithrombotic strategies of oral anticoagulation and dual antiplatelet drug is recently recommended in patiens with atrial fibrillation undergoing coronary stenting. However, triple therapy of warfarin, aspirin, and elopidogrel is associated with an in-creased risk of major bleeding. The safer and more effective joint approach has become the focus of this issue. The efficacy and safety of va- rious joint antithrombotic regimen are summarized in this paper. |
| |
| Keywords: | atrial fibrillation coronary stenting warfarin clopidogrel |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
